XML 78 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Instruments and Risk Management (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Notional Amounts of Outstanding Derivative Instruments

As of December 31, 2022, the Company had the following outstanding derivative instruments that were entered into to hedge Euro-denominated and Singapore dollar-denominated forecasted transactions:

 

In millions of Euros

 

Notional amount for hedge on

forecasted R&D and other

operating expenses

 

 

Notional amount for hedge on

forecasted manufacturing costs

 

Forward contracts

 

 

540

 

 

 

986

 

Currency collars

 

 

500

 

 

 

791

 

 

 

 

 

 

 

 

 

 

In millions of Singapore dollars

 

Notional amount for hedge on

forecasted R&D and other

operating expenses

 

 

Notional amount for hedge on

forecasted manufacturing costs

 

Forward contracts

 

 

 

 

 

247

 

Fair Value of Derivative Instruments

Information on fair value of derivative instruments and their location in the consolidated balance sheets as of December 31, 2022 and December 31, 2021 is presented in the table below:

 

 

 

 

 

As of December

31, 2022

 

 

As of December

31, 2021

 

Asset Derivatives

 

Balance sheet classification

 

Fair

value

 

 

Fair

value

 

Derivatives designated as a hedge:

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

 

37

 

 

 

2

 

Foreign exchange forward contracts

 

Other non-current assets

 

 

8

 

 

 

 

Currency collars

 

Other current assets

 

 

10

 

 

 

1

 

Currency collars

 

Other non-current assets

 

 

5

 

 

 

 

Total derivatives designated as a hedge:

 

 

 

 

60

 

 

 

3

 

Derivatives not designated as a hedge:

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

 

9

 

 

 

3

 

Total derivatives not designated as a hedge:

 

 

 

 

9

 

 

 

3

 

Total Derivatives

 

 

 

 

69

 

 

 

6

 

 

 

 

 

 

As of December

31, 2022

 

 

As of December

31, 2021

 

Liability Derivatives

 

Balance sheet classification

 

Fair

value

 

 

Fair

value

 

Derivatives designated as a hedge:

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other payables and

accrued liabilities

 

 

(23

)

 

 

(29

)

Foreign exchange forward contracts

 

Other non-current liabilities

 

 

(3

)

 

 

 

Currency collars

 

Other payables and

accrued liabilities

 

 

(9

)

 

 

(13

)

Currency collars

 

Other non-current liabilities

 

 

(1

)

 

 

 

Total derivatives designated as a hedge:

 

 

 

 

(36

)

 

 

(42

)

Derivatives not designated as a hedge:

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other payables and

accrued liabilities

 

 

(3

)

 

 

(1

)

Total derivatives not designated as a hedge:

 

 

 

 

(3

)

 

 

(1

)

Total Derivatives

 

 

 

 

(39

)

 

 

(43

)

Effect on Consolidated Statements of Income of Derivative Instruments

The effect of derivative instruments designated as cashflow hedge on the consolidated statements of income for the year ended December 31, 2022 and December 31, 2021 and on the “Accumulated other comprehensive income (loss)” (“AOCI”) as reported in the consolidated statements of equity as of December 31, 2022 and December 31, 2021 is presented in the table below:

 

 

 

Gain (loss) deferred in

OCI on derivative

 

 

Location of gain (loss)

 

Gain (loss) reclassified from

OCI into earnings

 

 

 

December 31,

2022

 

 

December 31,

2021

 

 

reclassified from OCI into

earnings

 

December 31,

2022

 

 

December 31,

2021

 

Foreign exchange forward

   contracts

 

 

14

 

 

 

(20

)

 

Cost of sales

 

 

(83

)

 

 

11

 

Foreign exchange forward

   contracts

 

 

2

 

 

 

(2

)

 

Selling, general and administrative

 

 

(9

)

 

 

 

Foreign exchange forward

   contracts

 

 

4

 

 

 

(9

)

 

Research and development

 

 

(32

)

 

 

1

 

Currency collars

 

 

1

 

 

 

(11

)

 

Cost of sales

 

 

(46

)

 

 

4

 

Currency collars

 

 

1

 

 

 

(1

)

 

Selling, general and administrative

 

 

(6

)

 

 

1

 

Currency collars

 

 

1

 

 

 

(5

)

 

Research and development

 

 

(21

)

 

 

2

 

Total

 

 

23

 

 

 

(48

)

 

 

 

 

(197

)

 

 

19

 

Effect on Consolidated Statements of Income of Derivative Instruments Not Designated as Hedge

The effect on the consolidated statements of income for the year ended December 31, 2022 and December 31, 2021 of derivative instruments not designated as a hedge is presented in the table below:

 

 

 

Location of gain

 

Gain (loss) recognized in earnings

 

 

 

(loss) recognized

in earnings

 

December 31,

2022

 

 

December 31,

2021

 

Foreign exchange forward contracts

 

Other income and expenses, net

 

 

24

 

 

 

9

 

Total

 

 

 

 

24

 

 

 

9

 

 

Schedule of Financial Assets (Liabilities) Measured at Fair Value on Recurring Basis

The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2022:

 

 

 

Fair Value Measurements using

 

 

December 31,

2022

 

Quoted

Prices in

Active

Markets for

Identical

Assets

(Level 1)

 

Significant

Other

Observable

Inputs

(Level 2)

 

Significant

Unobservable

Inputs

(Level 3)

Marketable securities – U.S. Treasury debt securities

 

679

 

679

 

 

Short-term deposits

 

581

 

581

 

 

Equity securities measured at fair value through earnings

 

26

 

26

 

 

Derivative assets designated as cash flow hedge

 

60

 

 

60

 

Derivative assets not designated as cash flow hedge

 

9

 

 

9

 

Derivative liabilities designated as cash flow hedge

 

(36)

 

 

(36)

 

Derivative liabilities not designated as cash flow hedge

 

(3)

 

 

(3)

 

Contingent consideration on business acquisitions

 

(31)

 

 

 

(31)

Total

 

1,285

 

1,286

 

30

 

(31)

 

The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2021:

 

 

 

Fair Value Measurements using

 

 

December 31,

2021

 

Quoted

Prices in

Active

Markets for

Identical

Assets

(Level 1)

 

Significant

Other

Observable

Inputs

(Level 2)

 

Significant

Unobservable

Inputs

(Level 3)

Short-term deposits

 

291

 

291

 

 

Equity securities measured at fair value through earnings

 

29

 

29

 

 

Derivative assets designated as cash flow hedge

 

3

 

 

3

 

Derivative assets not designated as cash flow hedge

 

3

 

 

3

 

Derivative liabilities designated as cash flow hedge

 

(42)

 

 

(42)

 

Derivative liabilities not designated as cash flow hedge

 

(1)

 

 

(1)

 

Contingent consideration on business acquisitions

 

(77)

 

 

 

(77)

Total

 

206

 

320

 

(37)

 

(77)

 

Schedule of Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Level 3)

For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2022 and December 31, 2022 is presented as follows:

 

For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2021 and December 31, 2021 is presented as follows:

 

 

 

Fair Value

Measurements

using Significant

Unobservable

Inputs (Level 3)

January 1, 2021

 

123

Changes in fair value measurement

 

(38)

Currency translation adjustment

 

(8)

December 31, 2021

 

77

Amount of total gains (losses) for the period included in earnings attributable to liabilities

   still held at the reporting date

 

(2)

 

Fair Value Information on Other Financial Assets and Liabilities Recorded at Amortized Cost

The following table includes additional fair value information on financial assets and liabilities as of December 31, 2022 and 2021:

 

 

 

2022

 

2021

 

 

Level

 

Carrying

Amount

 

Estimated

Fair Value

 

Carrying

Amount

 

Estimated

Fair Value

Cash equivalents(1)

 

1

 

2,996

 

2,996

 

2,883

 

2,883

Short-term, deposits

 

1

 

581

 

581

 

291

 

291

Long-term debt

 

 

 

 

 

 

 

 

 

 

– Bank loans (including current portion)

 

2

 

1,165

 

1,165

 

1,152

 

1,152

– Finance leases (including current portion)

 

2

 

57

 

57

 

 

– Senior unsecured convertible bonds issued on August 4, 2020(2)

 

1

 

1,495

 

1,561

 

1,387

 

1,975

 

(1)

Cash equivalents primarily correspond to deposits at call with banks.

(2)

The carrying amount as of December 31, 2022, of the senior unsecured convertible bonds as reported above, corresponds to the nominal value of the bonds, net of $5 million unamortized debt issuance costs, in compliance with the new accounting guidance. The impact of the adoption is described in Note 2 and Note 15. The fair value represented the market price of the bonds trading on the Frankfurt Stock Exchange.

Schedule of Methodologies Used to Estimate Fair Value

The methodologies used to estimate fair value are as follows:

 

Components

Methodology used to estimate fair value

Debt securities classified as available-for-sale

Quoted market prices for identical instruments

Foreign exchange forward contracts, currency options and collars

Quoted market prices for similar instruments

Equity securities measured at fair value through earnings

Quoted market prices for identical instruments

Equity securities carried at cost as a measurement alternative

Valuation of the underlying investments on a new round of third-party financing or upon liquidation

Long-term debt and current portion of long-term debt

Future cash flows on a borrowing-by-borrowing basis and discounting these future cash flows using the Company's incremental borrowing rates for similar types of borrowing arrangements

Cash and cash equivalents, short-term deposits, accounts receivable, short-term borrowings, and accounts payable

The carrying amounts reflected in the consolidated financial statements are considered as reasonable estimates of fair value due to the relatively short period of time between the origination of the instruments and their expected realization.